Invesco Ltd. Anavex Life Sciences Corp. Transaction History

Invesco Ltd.

$557 Billion
Q2 2025

A detailed history of Invesco Ltd. transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Invesco Ltd. holds 863,959 shares of AVXL stock, worth $9.31 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

863,959

Previous 554,354 55.85%

Holding current value

$9.31 Million

Previous $4.76 Million 67.47%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$7.37 - $9.63 $2.28 Million - $2.98 Million	309,605 Added 55.85%	863,959 $7.97 Million
Q1 2025 May 12, 2025	SELL	$7.85 - $13.46 $476,447 - $816,941	-60,694 Reduced 9.87%	554,354 $4.76 Million
Q4 2024 Feb 13, 2025	BUY	$5.11 - $12.56 $3.02 Million - $7.42 Million	590,639 Added 2419.76%	615,048 $6.61 Million
Q3 2024 Nov 12, 2024	SELL	$4.11 - $7.04 $3,596 - $6,160	-875 Reduced 3.46%	24,409 $138,000
Q2 2024 Aug 13, 2024	SELL	$3.39 - $5.02 $10,020 - $14,839	-2,956 Reduced 10.47%	25,284 $106,000
Q1 2024 May 14, 2024	BUY	$4.55 - $6.75 $1,392 - $2,065	306 Added 1.1%	28,240 $143,000
Q4 2023 Feb 12, 2024	SELL	$5.04 - $9.95 $117,547 - $232,063	-23,323 Reduced 45.5%	27,934 $260,000
Q3 2023 Nov 13, 2023	BUY	$6.55 - $9.37 $128,399 - $183,680	19,603 Added 61.93%	51,257 $335,000
Q2 2023 Aug 11, 2023	SELL	$7.66 - $9.5 $1,830 - $2,270	-239 Reduced 0.75%	31,654 $257,000
Q1 2023 May 12, 2023	BUY	$8.32 - $11.75 $13,320 - $18,811	1,601 Added 5.29%	31,893 $273,000
Q4 2022 Feb 13, 2023	SELL	$7.65 - $14.43 $22,177 - $41,832	-2,899 Reduced 8.73%	30,292 $280,000
Q3 2022 Nov 14, 2022	BUY	$8.9 - $12.86 $31,274 - $45,190	3,514 Added 11.84%	33,191 $342,000
Q2 2022 Aug 15, 2022	SELL	$7.31 - $12.84 $4,905 - $8,615	-671 Reduced 2.21%	29,677 $297,000
Q1 2022 May 16, 2022	SELL	$9.74 - $17.69 $3.94 Million - $7.16 Million	-404,891 Reduced 93.03%	30,348 $374,000
Q4 2021 Feb 14, 2022	BUY	$16.88 - $23.31 $6.73 Million - $9.29 Million	398,718 Added 1091.75%	435,239 $7.55 Million
Q3 2021 Nov 15, 2021	SELL	$16.82 - $25.75 $9.45 Million - $14.5 Million	-561,977 Reduced 93.9%	36,521 $655,000
Q2 2021 Aug 17, 2021	SELL	$10.16 - $28.86 $5.35 Million - $15.2 Million	-526,867 Reduced 46.82%	598,498 $13.7 Million
Q1 2021 May 17, 2021	BUY	$5.17 - $16.13 $4.66 Million - $14.5 Million	900,652 Added 400.8%	1,125,365 $16.8 Million
Q4 2020 Feb 16, 2021	BUY	$4.01 - $7.58 $901,099 - $1.7 Million	224,713 New	224,713 $1.21 Million
Q3 2020 Nov 16, 2020	SELL	$3.8 - $5.0 $505,419 - $665,025	-133,005 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$2.62 - $5.2 $348,473 - $691,626	133,005 New	133,005 $654,000

Others Institutions Holding AVXL

# of Institutions

197

Shares Held

31.8M

Call Options Held

1.31M

Put Options Held

875K

View Full List

About ANAVEX LIFE SCIENCES CORP.

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $840M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

More about AVXL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account